Cleveland BioLabs Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
11.3 M |
Public Float |
4.71 M |
Cleveland BioLabs Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.29 |
Market Cap |
$17.19 M |
Shares Outstanding |
11.3 M |
Public Float |
4.8 M |
Address |
73 High Street Buffalo New York 14203 United States |
Employees | - |
Website | http://www.cbiolabs.com |
Updated | 07/08/2019 |
Cleveland BioLabs, Inc. is a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. |